Clinical Characteristics and Outcomes of Diabetic Ketoacidosis in Patients With Type 2 Diabetes using SGLT2 Inhibitors

Background: Sodium glucose cotransporter 2 inhibitors (SGLT2i) use is associated with an increased risk of diabetic ketoacidosis (DKA). Objective: This study evaluated and compared the DKA characteristics and outcomes of users and non-users of SGLT2i. Methods: We retrospectively studied patients wit...

Full description

Bibliographic Details
Main Authors: Raya Almazrouei, Bachar Afandi, Fatima AlKindi, Romona Govender, Saif Al-Shamsi
Format: Article
Language:English
Published: SAGE Publishing 2023-02-01
Series:Clinical Medicine Insights: Endocrinology and Diabetes
Online Access:https://doi.org/10.1177/11795514231153717